These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 20527061)
21. Lack of efficacy of prophylactic platelet transfusion for severe thrombocytopenia in adults with acute uncomplicated dengue infection. Lye DC; Lee VJ; Sun Y; Leo YS Clin Infect Dis; 2009 May; 48(9):1262-5. PubMed ID: 19292665 [TBL] [Abstract][Full Text] [Related]
22. Clinical evaluation of platelet transfusions in thrombocytopenic patients: methods and interpretation. Kahn RA Vox Sang; 1981; 40 Suppl 1():87-97. PubMed ID: 7293125 [No Abstract] [Full Text] [Related]
24. They took a mulligan and mostly got it right … the issue of prophylactic platelet transfusion for patients receiving autologous stem cell transplantation. Schiffer CA Transfusion; 2014 Oct; 54(10):2372-4. PubMed ID: 25302734 [No Abstract] [Full Text] [Related]
25. The blood bank physician as a hemostasis consultant. Sweeney JD Transfus Apher Sci; 2008 Oct; 39(2):145-50. PubMed ID: 18760674 [TBL] [Abstract][Full Text] [Related]
26. Fecal blood loss: A quantitative method of evaluating hemostasis in patients with thrombocytopenia. Slichter SJ; Gernsheimer T; LeBlanc R; Townsend-McCall D; Jones MK; Cuaron L; Bolgiano D Transfusion; 2021 Feb; 61(2):393-403. PubMed ID: 33166412 [TBL] [Abstract][Full Text] [Related]
27. Thrombocytopenia and platelet transfusions in patients with cancer. Valent J; Schiffer CA Cancer Treat Res; 2011; 157():251-65. PubMed ID: 21052961 [TBL] [Abstract][Full Text] [Related]
28. Efficacy of prophylactic transfusions using single donor apheresis platelets versus pooled platelet concentrates in AML/MDS patients receiving allogeneic hematopoietic stem cell transplantation. Gurkan E; Patah PA; Saliba RM; Ramos CA; Anderson BS; Champlin R; de Lima M; Lichtiger B Bone Marrow Transplant; 2007 Sep; 40(5):461-4. PubMed ID: 17589530 [TBL] [Abstract][Full Text] [Related]
29. Template bleeding times of 240 neonates born at 24 to 41 weeks gestation. Del Vecchio A; Latini G; Henry E; Christensen RD J Perinatol; 2008 Jun; 28(6):427-31. PubMed ID: 18273029 [TBL] [Abstract][Full Text] [Related]
35. [Indications and contraindications for platelet transfusions in patients with thrombocytopenia]. Tomicić M; Vuk T; Hundrić-Haspl Z Lijec Vjesn; 2014; 136(3-4):90-3. PubMed ID: 24988744 [TBL] [Abstract][Full Text] [Related]
36. A therapeutic platelet transfusion strategy is safe and feasible in patients after autologous peripheral blood stem cell transplantation. Wandt H; Schaefer-Eckart K; Frank M; Birkmann J; Wilhelm M Bone Marrow Transplant; 2006 Feb; 37(4):387-92. PubMed ID: 16400342 [TBL] [Abstract][Full Text] [Related]
37. What is the proper threshold for platelet transfusion in patients with chemotherapy-induced thrombocytopenia? Benjamin RJ; Anderson KC Crit Rev Oncol Hematol; 2002 May; 42(2):163-71. PubMed ID: 12007974 [TBL] [Abstract][Full Text] [Related]
38. Acute bleeding complications in patients after hematopoietic stem cell transplantation with prophylactic platelet transfusion triggers of 10 x 10(9) and 20 x 10(9) per L. Nevo S; Fuller AK; Hartley E; Borinsky ME; Vogelsang GB Transfusion; 2007 May; 47(5):801-12. PubMed ID: 17465944 [TBL] [Abstract][Full Text] [Related]